应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
JSPR Jasper Therapeutics
休市中 12-05 16:00:00 EST
1.71
-0.15
-8.06%
盘后
1.66
-0.05
-2.89%
19:31 EST
最高
1.93
最低
1.69
成交量
113.26万
今开
1.85
昨收
1.86
日振幅
12.87%
总市值
4,785万
流通市值
3,901万
总股本
2,798万
成交额
202.21万
换手率
4.97%
流通股本
2,281万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Jasper Therapeutics:Briquilimab在研究中耐受性良好,显示出有利的安全性概况
美股速递 · 12-02
Jasper Therapeutics:Briquilimab在研究中耐受性良好,显示出有利的安全性概况
Jasper Therapeutics公布Etesian研究中Briquilimab在哮喘治疗中的积极初步数据及Beacon研究内部调查发现
美股速递 · 12-02
Jasper Therapeutics公布Etesian研究中Briquilimab在哮喘治疗中的积极初步数据及Beacon研究内部调查发现
Jasper Therapeutics 完成内部 Beacon 研究调查,未发现药品使用偏差或问题
美股速递 · 12-02
Jasper Therapeutics 完成内部 Beacon 研究调查,未发现药品使用偏差或问题
Jasper Therapeutics, Inc.盘中异动 下午盘快速拉升5.88%
市场透视 · 11-13
Jasper Therapeutics, Inc.盘中异动 下午盘快速拉升5.88%
Jasper Therapeutics, Inc.盘中异动 快速上涨7.12%
市场透视 · 09-25
Jasper Therapeutics, Inc.盘中异动 快速上涨7.12%
Jasper Therapeutics盘后股价下跌9.7%,宣布拟公开发行普通股、预付权证及普通权证
美股速递 · 09-19
Jasper Therapeutics盘后股价下跌9.7%,宣布拟公开发行普通股、预付权证及普通权证
Jasper Therapeutics宣布拟进行普通股、预付费认股权证和普通认股权证公开发行
美股速递 · 09-19
Jasper Therapeutics宣布拟进行普通股、预付费认股权证和普通认股权证公开发行
Jasper Therapeutics, Inc.盘中异动 快速上涨5.61%
市场透视 · 08-11
Jasper Therapeutics, Inc.盘中异动 快速上涨5.61%
Jasper Therapeutics, Inc.盘中异动 下午盘急速跳水6.03%报2.73美元
市场透视 · 08-08
Jasper Therapeutics, Inc.盘中异动 下午盘急速跳水6.03%报2.73美元
Jasper Therapeutics, Inc.盘中异动 下午盘快速下挫5.48%报2.93美元
市场透视 · 07-30
Jasper Therapeutics, Inc.盘中异动 下午盘快速下挫5.48%报2.93美元
Jasper Therapeutics, Inc.盘中异动 股价大涨5.07%
市场透视 · 07-17
Jasper Therapeutics, Inc.盘中异动 股价大涨5.07%
Jasper Therapeutics, Inc.盘中异动 临近午盘快速下跌5.16%报3.49美元
市场透视 · 07-10
Jasper Therapeutics, Inc.盘中异动 临近午盘快速下跌5.16%报3.49美元
Jasper Therapeutics荨麻疹研究数据混乱,股价暴跌,研发计划受阻
药事纵横 · 07-09
Jasper Therapeutics荨麻疹研究数据混乱,股价暴跌,研发计划受阻
Jasper Therapeutics, Inc.盘中异动 大幅下挫64.99%报2.37美元
市场透视 · 07-07
Jasper Therapeutics, Inc.盘中异动 大幅下挫64.99%报2.37美元
Jasper Therapeutics, Inc.盘中异动 大幅上涨6.10%报6.09美元
市场透视 · 07-02
Jasper Therapeutics, Inc.盘中异动 大幅上涨6.10%报6.09美元
Jasper Therapeutics, Inc.盘中异动 临近收盘股价大跌5.89%报5.36美元
市场透视 · 06-28
Jasper Therapeutics, Inc.盘中异动 临近收盘股价大跌5.89%报5.36美元
Jasper Therapeutics, Inc.盘中异动 大幅拉升5.07%报5.39美元
市场透视 · 06-24
Jasper Therapeutics, Inc.盘中异动 大幅拉升5.07%报5.39美元
Jasper Therapeutics, Inc.盘中异动 急速拉升6.21%报5.47美元
市场透视 · 06-23
Jasper Therapeutics, Inc.盘中异动 急速拉升6.21%报5.47美元
Jasper Therapeutics, Inc.盘中异动 股价大跌5.17%
市场透视 · 06-06
Jasper Therapeutics, Inc.盘中异动 股价大跌5.17%
Jasper Therapeutics, Inc.盘中异动 早盘急速下挫5.03%
市场透视 · 03-10
Jasper Therapeutics, Inc.盘中异动 早盘急速下挫5.03%
加载更多
公司概况
公司名称:
Jasper Therapeutics
所属市场:
NASDAQ
上市日期:
--
主营业务:
Jasper Therapeutics, Inc.于2019年8月13日在特拉华州成立。该公司是一家临床阶段的生物技术公司,致力于通过针对肥大和造血干细胞的疗法实现治疗。该公司专注于开发和商业化更安全、更有效的治疗药物,用于治疗慢性自发性荨麻疹、低至中度风险骨髓增生异常综合征等疾病,以及干细胞移植和离体基因治疗的新型调理方案,这是一种在移植前在体外对细胞进行基因操作的技术。
发行价格:
--
{"stockData":{"symbol":"JSPR","market":"US","secType":"STK","nameCN":"Jasper Therapeutics","latestPrice":1.71,"timestamp":1764968400000,"preClose":1.86,"halted":0,"volume":1132581,"hourTrading":{"tag":"盘后","latestPrice":1.6606,"preClose":1.71,"latestTime":"19:31 EST","volume":26338,"amount":44399.4426,"timestamp":1764981081541},"delay":0,"floatShares":22810300,"shares":27984039,"eps":-5.78681,"marketStatus":"休市中","change":-0.15,"latestTime":"12-05 16:00:00 EST","open":1.85,"high":1.93,"low":1.6907,"amount":2022075.3471633,"amplitude":0.128656,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-5.78681,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1765184400000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":1.86,"preHourTrading":{"tag":"盘前","latestPrice":1.86,"preClose":1.86,"latestTime":"09:27 EST","volume":23565,"amount":42427.69851,"timestamp":1764944860022},"postHourTrading":{"tag":"盘后","latestPrice":1.6606,"preClose":1.71,"latestTime":"19:31 EST","volume":26338,"amount":44399.4426,"timestamp":1764981081541},"volumeRatio":0.08372690914040043,"impliedVol":1.7171,"impliedVolPercentile":0.604},"requestUrl":"/m/hq/s/JSPR","defaultTab":"news","newsList":[{"id":"1146489069","title":"Jasper Therapeutics:Briquilimab在研究中耐受性良好,显示出有利的安全性概况","url":"https://stock-news.laohu8.com/highlight/detail?id=1146489069","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1146489069?lang=zh_cn&edition=full","pubTime":"2025-12-02 20:00","pubTimestamp":1764676850,"startTime":"0","endTime":"0","summary":"Jasper Therapeutics:Briquilimab在研究中耐受性良好,显示出有利的安全性概况","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","JSPR"],"gpt_icon":0},{"id":"1112115488","title":"Jasper Therapeutics公布Etesian研究中Briquilimab在哮喘治疗中的积极初步数据及Beacon研究内部调查发现","url":"https://stock-news.laohu8.com/highlight/detail?id=1112115488","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1112115488?lang=zh_cn&edition=full","pubTime":"2025-12-02 20:00","pubTimestamp":1764676849,"startTime":"0","endTime":"0","summary":"Jasper Therapeutics公布Etesian研究中Briquilimab在哮喘治疗中的积极初步数据及Beacon研究内部调查发现","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","JSPR"],"gpt_icon":0},{"id":"1110443782","title":"Jasper Therapeutics 完成内部 Beacon 研究调查,未发现药品使用偏差或问题","url":"https://stock-news.laohu8.com/highlight/detail?id=1110443782","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1110443782?lang=zh_cn&edition=full","pubTime":"2025-12-02 20:00","pubTimestamp":1764676848,"startTime":"0","endTime":"0","summary":"Jasper Therapeutics 完成内部 Beacon 研究调查,未发现药品使用偏差或问题。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","JSPR"],"gpt_icon":0},{"id":"2583536900","title":"Jasper Therapeutics, Inc.盘中异动 下午盘快速拉升5.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2583536900","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583536900?lang=zh_cn&edition=full","pubTime":"2025-11-13 02:31","pubTimestamp":1762972304,"startTime":"0","endTime":"0","summary":"北京时间2025年11月13日02时31分,Jasper Therapeutics, Inc.股票出现异动,股价大幅拉升5.88%。Jasper Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.90%。其相关个股中,Leap Therapeutics, Inc.、Salarius Pharmaceuticals, Inc.、Yd Bio Ltd C/Wts 28/08/2030涨幅较大,Salarius Pharmaceuticals, Inc.、Leap Therapeutics, Inc.、Clearmind Medicine Inc.较为活跃,换手率分别为6832.72%、1055.70%、617.42%,振幅较大的相关个股有Leap Therapeutics, Inc.、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 、Salarius Pharmaceuticals, Inc.,振幅分别为350.86%、76.39%、62.24%。Jasper Therapeutics, Inc.公司简介:Jasper Therapeutics Inc 是一家临床阶段的生物技术公司,致力于通过造血干细胞疗法实现治愈。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251113023144a6f50bcf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251113023144a6f50bcf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","JSPR","LENZ","BK4139","BK4539"],"gpt_icon":0},{"id":"2570202013","title":"Jasper Therapeutics, Inc.盘中异动 快速上涨7.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2570202013","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2570202013?lang=zh_cn&edition=full","pubTime":"2025-09-25 21:34","pubTimestamp":1758807240,"startTime":"0","endTime":"0","summary":"北京时间2025年09月25日21时34分,Jasper Therapeutics, Inc.股票出现波动,股价快速上涨7.12%。Jasper Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.09%。其相关个股中,Pepgen Inc.、Scisparc Ltd.、Plus Therapeutics, Inc.涨幅较大,Scisparc Ltd.、Evaxion A/S、Pepgen Inc.较为活跃,换手率分别为1417.65%、697.90%、194.37%,振幅较大的相关个股有Scisparc Ltd.、Plus Therapeutics, Inc.、Pepgen Inc.,振幅分别为18.28%、16.92%、15.04%。Jasper Therapeutics, Inc.公司简介:Jasper Therapeutics Inc 是一家临床阶段的生物技术公司,致力于通过造血干细胞疗法实现治愈。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250925213400a69dcea5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250925213400a69dcea5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","JSPR","BK4539","LENZ","BK4139"],"gpt_icon":0},{"id":"1111900861","title":"Jasper Therapeutics盘后股价下跌9.7%,宣布拟公开发行普通股、预付权证及普通权证","url":"https://stock-news.laohu8.com/highlight/detail?id=1111900861","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1111900861?lang=zh_cn&edition=full","pubTime":"2025-09-19 04:25","pubTimestamp":1758227116,"startTime":"0","endTime":"0","summary":"Jasper Therapeutics在盘后交易中股价下跌9.7%,该公司同时宣布计划进行一项公开发行,包括普通股、预付权证和普通权证的发行。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JSPR","BK4139"],"gpt_icon":0},{"id":"1163623490","title":"Jasper Therapeutics宣布拟进行普通股、预付费认股权证和普通认股权证公开发行","url":"https://stock-news.laohu8.com/highlight/detail?id=1163623490","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1163623490?lang=zh_cn&edition=full","pubTime":"2025-09-19 04:09","pubTimestamp":1758226156,"startTime":"0","endTime":"0","summary":"Jasper Therapeutics宣布拟进行普通股、预付费认股权证和普通认股权证公开发行。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JSPR","BK4139"],"gpt_icon":0},{"id":"2558966690","title":"Jasper Therapeutics, Inc.盘中异动 快速上涨5.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2558966690","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558966690?lang=zh_cn&edition=full","pubTime":"2025-08-11 21:55","pubTimestamp":1754920536,"startTime":"0","endTime":"0","summary":"北京时间2025年08月11日21时55分,Jasper Therapeutics, Inc.股票出现异动,股价大幅拉升5.61%。Jasper Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.24%。其相关个股中,Equillium, Inc.、Entero Therapeutics Inc.、Neurosense Therapeutics Ltd C/Wts 10/11/2026 涨幅较大,Entero Therapeutics Inc.、Equillium, Inc.、Io Biotech, Inc.较为活跃,换手率分别为3366.22%、286.73%、85.00%,振幅较大的相关个股有Entero Therapeutics Inc.、Equillium, Inc.、Neurosense Therapeutics Ltd C/Wts 10/11/2026 ,振幅分别为74.27%、70.68%、30.00%。Jasper Therapeutics, Inc.公司简介:Jasper Therapeutics Inc 是一家临床阶段的生物技术公司,致力于通过造血干细胞疗法实现治愈。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081121553694dcc8cd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081121553694dcc8cd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","JSPR","LENZ","BK4539"],"gpt_icon":0},{"id":"2557936345","title":"Jasper Therapeutics, Inc.盘中异动 下午盘急速跳水6.03%报2.73美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557936345","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557936345?lang=zh_cn&edition=full","pubTime":"2025-08-08 02:25","pubTimestamp":1754591155,"startTime":"0","endTime":"0","summary":"北京时间2025年08月08日02时25分,Jasper Therapeutics, Inc.股票出现波动,股价急速下跌6.03%。Jasper Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.52%。其相关个股中,60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Cingulate Inc C/Wts 10/12/2026 、C4 Therapeutics, Inc.涨幅较大,Palisade Bio, Inc.、Bioxcel Therapeutics, Inc.、Tnf Pharmaceuticals, Inc.较为活跃,换手率分别为1836.27%、215.96%、104.04%,振幅较大的相关个股有Palisade Bio, Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Omniab Inc C/Wts ,振幅分别为103.00%、82.50%、58.33%。Jasper Therapeutics, Inc.公司简介:Jasper Therapeutics Inc 是一家临床阶段的生物技术公司,致力于通过造血干细胞疗法实现治愈。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808022556a6d952ec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808022556a6d952ec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","JSPR","LENZ","BK4139","BK4539"],"gpt_icon":0},{"id":"2555798063","title":"Jasper Therapeutics, Inc.盘中异动 下午盘快速下挫5.48%报2.93美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555798063","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555798063?lang=zh_cn&edition=full","pubTime":"2025-07-30 01:39","pubTimestamp":1753810781,"startTime":"0","endTime":"0","summary":"北京时间2025年07月30日01时39分,Jasper Therapeutics, Inc.股票出现波动,股价快速跳水5.48%。Jasper Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.60%。其相关个股中,Salarius Pharmaceuticals, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 涨幅较大,Scinai Immunotherapeutics Ltd、Salarius Pharmaceuticals, Inc.、Tnf Pharmaceuticals, Inc.较为活跃,换手率分别为5506.19%、3705.59%、1746.90%,振幅较大的相关个股有Salarius Pharmaceuticals, Inc.、180 Life Sciences Corp C/Wts 07/11/2025、180 Life Sciences Corp.,振幅分别为176.76%、111.54%、75.60%。Jasper Therapeutics, Inc.公司简介:Jasper Therapeutics Inc 是一家临床阶段的生物技术公司,致力于通过造血干细胞疗法实现治愈。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730013941a46a0c9f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730013941a46a0c9f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","JSPR","BK4139","LENZ","BK4007"],"gpt_icon":0},{"id":"2552487732","title":"Jasper Therapeutics, Inc.盘中异动 股价大涨5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2552487732","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552487732?lang=zh_cn&edition=full","pubTime":"2025-07-17 22:31","pubTimestamp":1752762675,"startTime":"0","endTime":"0","summary":"北京时间2025年07月17日22时31分,Jasper Therapeutics, Inc.股票出现异动,股价快速上涨5.07%。Jasper Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.29%。其相关个股中,Lexaria Bioscience Corp C/Wts 14/01/2026 、Marker Therapeutics, Inc.、Windtree Therapeutics, Inc.涨幅较大,Windtree Therapeutics, Inc.、Marker Therapeutics, Inc.、Immuron Limited较为活跃,换手率分别为852.76%、348.88%、187.74%,振幅较大的相关个股有Marker Therapeutics, Inc.、Windtree Therapeutics, Inc.、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 ,振幅分别为148.12%、81.11%、61.18%。Jasper Therapeutics, Inc.公司简介:Jasper Therapeutics Inc 是一家临床阶段的生物技术公司,致力于通过造血干细胞疗法实现治愈。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717223116a4515a66&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717223116a4515a66&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","BK4539","BK4007","JSPR"],"gpt_icon":0},{"id":"2550622179","title":"Jasper Therapeutics, Inc.盘中异动 临近午盘快速下跌5.16%报3.49美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550622179","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550622179?lang=zh_cn&edition=full","pubTime":"2025-07-10 23:51","pubTimestamp":1752162703,"startTime":"0","endTime":"0","summary":"北京时间2025年07月10日23时51分,Jasper Therapeutics, Inc.股票出现波动,股价大幅下跌5.16%。Jasper Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.61%。其相关个股中,Q32 Bio Inc.、Cognition Therapeutics, Inc.、Calidi Biotherapeutics, Inc.涨幅较大,Cognition Therapeutics, Inc.、Q32 Bio Inc.、Calidi Biotherapeutics, Inc.较为活跃,换手率分别为358.08%、258.05%、185.22%,振幅较大的相关个股有Q32 Bio Inc.、Cognition Therapeutics, Inc.、Pelthos Therapeutics Inc.,振幅分别为90.07%、73.27%、68.61%。Jasper Therapeutics, Inc.公司简介:Jasper Therapeutics Inc 是一家临床阶段的生物技术公司,致力于通过造血干细胞疗法实现治愈。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071023514497a12518&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071023514497a12518&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4539","BK4007","BK4139","JSPR"],"gpt_icon":0},{"id":"2550576361","title":"Jasper Therapeutics荨麻疹研究数据混乱,股价暴跌,研发计划受阻","url":"https://stock-news.laohu8.com/highlight/detail?id=2550576361","media":"药事纵横","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550576361?lang=zh_cn&edition=full","pubTime":"2025-07-09 06:02","pubTimestamp":1752012162,"startTime":"0","endTime":"0","summary":"7月7日,Jasper Therapeutics的股价暴跌了55%。据Jasper公司称,在其针对慢性自发性荨麻疹的1b/2a期BEACON研究中,一个药物批次出现了问题,导致两个剂量组的研究结果不可靠。Jasper的主打资产briquilimab是一种单克隆抗体,通过靶向KIT受体来耗竭引发慢性荨麻疹和哮喘的肥大细胞。Jasper公司正在调查这一问题,并预计在未来几周内得出结果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709060518a43ebd5b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709060518a43ebd5b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","JSPR","BK4139","BK4539"],"gpt_icon":0},{"id":"2549558334","title":"Jasper Therapeutics, Inc.盘中异动 大幅下挫64.99%报2.37美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2549558334","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549558334?lang=zh_cn&edition=full","pubTime":"2025-07-07 21:31","pubTimestamp":1751895108,"startTime":"0","endTime":"0","summary":"北京时间2025年07月07日21时31分,Jasper Therapeutics, Inc.股票出现异动,股价急速下挫64.99%。Jasper Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.09%。其相关个股中,Mustang Bio, Inc.、Artelo Biosciences, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 涨幅较大,Mustang Bio, Inc.、Artelo Biosciences, Inc.、Sonnet Biotherapeutics Holdings, Inc.较为活跃,换手率分别为1370.96%、744.87%、657.19%,振幅较大的相关个股有Nucana Plc、Mustang Bio, Inc.、Exicure, Inc.,振幅分别为11.94%、10.04%、9.29%。Jasper Therapeutics, Inc.公司简介:Jasper Therapeutics Inc 是一家临床阶段的生物技术公司,致力于通过造血干细胞疗法实现治愈。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707213148a69b1973&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707213148a69b1973&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","JSPR","BK4139","BK4007","BK4539"],"gpt_icon":0},{"id":"2548689003","title":"Jasper Therapeutics, Inc.盘中异动 大幅上涨6.10%报6.09美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548689003","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548689003?lang=zh_cn&edition=full","pubTime":"2025-07-02 21:48","pubTimestamp":1751464088,"startTime":"0","endTime":"0","summary":"北京时间2025年07月02日21时48分,Jasper Therapeutics, Inc.股票出现波动,股价快速上涨6.10%。Jasper Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.36%。其相关个股中,Nutriband Inc C/Wts 、Lixte Biotechnology Holdings Inc C/Wts 30/11/2025 、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025涨幅较大,Windtree Therapeutics, Inc.、Aditxt, Inc.、Oragenics Inc.较为活跃,换手率分别为1555.45%、122.52%、84.59%,振幅较大的相关个股有Pasithea Therapeutics Corp C/Wts 12/08/2026 、Lixte Biotechnology Holdings Inc C/Wts 30/11/2025 、Nutriband Inc C/Wts ,振幅分别为78.85%、60.09%、47.46%。Jasper Therapeutics, Inc.公司简介:Jasper Therapeutics Inc 是一家临床阶段的生物技术公司,致力于通过造血干细胞疗法实现治愈。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025070221480997975a97&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025070221480997975a97&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","BK4539","BK4007","JSPR"],"gpt_icon":0},{"id":"2546729951","title":"Jasper Therapeutics, Inc.盘中异动 临近收盘股价大跌5.89%报5.36美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546729951","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546729951?lang=zh_cn&edition=full","pubTime":"2025-06-28 03:50","pubTimestamp":1751053815,"startTime":"0","endTime":"0","summary":"北京时间2025年06月28日03时50分,Jasper Therapeutics, Inc.股票出现异动,股价急速下挫5.89%。Jasper Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.74%。其相关个股中,Eyenovia, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、天境生物涨幅较大,Inmune Bio Inc.、Hcw Biologics Inc.、Conduit Pharmaceuticals Inc.较为活跃,换手率分别为245.53%、168.76%、137.57%,振幅较大的相关个股有Inmune Bio Inc.、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Channel Therapeutics Corporation,振幅分别为105.57%、74.75%、64.91%。Jasper Therapeutics, Inc.公司简介:Jasper Therapeutics Inc 是一家临床阶段的生物技术公司,致力于通过造血干细胞疗法实现治愈。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250628035015a7217370&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250628035015a7217370&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","JSPR","LENZ","BK4139","BK4539"],"gpt_icon":0},{"id":"2545392622","title":"Jasper Therapeutics, Inc.盘中异动 大幅拉升5.07%报5.39美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2545392622","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545392622?lang=zh_cn&edition=full","pubTime":"2025-06-24 23:21","pubTimestamp":1750778482,"startTime":"0","endTime":"0","summary":"北京时间2025年06月24日23时21分,Jasper Therapeutics, Inc.股票出现波动,股价急速上涨5.07%。Jasper Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为1.71%。其相关个股中,Apollomics Inc C/Wts 01/04/2028 、内克塔治疗、Eyenovia, Inc.涨幅较大,Nucana Plc、Eyenovia, Inc.、Adial Pharmaceuticals, Inc较为活跃,换手率分别为860.02%、546.26%、522.89%,振幅较大的相关个股有Apollomics Inc C/Wts 01/04/2028 、Eyenovia, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 ,振幅分别为176.26%、85.77%、69.60%。Jasper Therapeutics, Inc.公司简介:Jasper Therapeutics Inc 是一家临床阶段的生物技术公司,致力于通过造血干细胞疗法实现治愈。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624232123978d07bd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624232123978d07bd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","BK4539","BK4007","JSPR"],"gpt_icon":0},{"id":"2545443164","title":"Jasper Therapeutics, Inc.盘中异动 急速拉升6.21%报5.47美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2545443164","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545443164?lang=zh_cn&edition=full","pubTime":"2025-06-23 23:10","pubTimestamp":1750691426,"startTime":"0","endTime":"0","summary":"北京时间2025年06月23日23时10分,Jasper Therapeutics, Inc.股票出现波动,股价快速上涨6.21%。Jasper Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.18%。其相关个股中,Impact Biomedical, Inc.、Indaptus Therapeutics, Inc.、Cidara Therapeutics, Inc.涨幅较大,Impact Biomedical, Inc.、Indaptus Therapeutics, Inc.、Nucana Plc较为活跃,换手率分别为2089.22%、1840.13%、635.40%,振幅较大的相关个股有Impact Biomedical, Inc.、Indaptus Therapeutics, Inc.、Immatics N V C/Wts 01/07/2025 ,振幅分别为218.17%、79.75%、71.02%。Jasper Therapeutics, Inc.公司简介:Jasper Therapeutics Inc 是一家临床阶段的生物技术公司,致力于通过造血干细胞疗法实现治愈。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025062323102795282fe7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025062323102795282fe7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","BK4539","LENZ","JSPR"],"gpt_icon":0},{"id":"2541200008","title":"Jasper Therapeutics, Inc.盘中异动 股价大跌5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2541200008","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2541200008?lang=zh_cn&edition=full","pubTime":"2025-06-06 02:58","pubTimestamp":1749149902,"startTime":"0","endTime":"0","summary":"北京时间2025年06月06日02时58分,Jasper Therapeutics, Inc.股票出现波动,股价急速下跌5.17%。Jasper Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.15%。其相关个股中,Liminatus Pharma Inc C/Wts 30/04/2030 、Immatics N V C/Wts 01/07/2025 、Liminatus Pharma, Inc.涨幅较大,Scinai Immunotherapeutics Ltd、Nucana Plc、Eyenovia, Inc.较为活跃,换手率分别为1984.99%、916.62%、299.76%,振幅较大的相关个股有Liminatus Pharma Inc C/Wts 30/04/2030 、Scinai Immunotherapeutics Ltd、Liminatus Pharma, Inc.,振幅分别为145.64%、142.06%、75.39%。Jasper Therapeutics, Inc.公司简介:Jasper Therapeutics Inc 是一家临床阶段的生物技术公司,致力于通过造血干细胞疗法实现治愈。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250606025822977356b3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250606025822977356b3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","JSPR","BK4139","BK4007","BK4539"],"gpt_icon":0},{"id":"2518276252","title":"Jasper Therapeutics, Inc.盘中异动 早盘急速下挫5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518276252","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518276252?lang=zh_cn&edition=full","pubTime":"2025-03-10 22:19","pubTimestamp":1741616350,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日22时19分,Jasper Therapeutics, Inc.股票出现异动,股价急速下挫5.03%。Jasper Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.35%。其相关个股中,Checkpoint Therapeutics, Inc.、Mineralys Therapeutics, Inc.、Trevi Therapeutics, Inc.涨幅较大,Biodexa Pharmaceuticals Plc、Scisparc Ltd.、Dogwood Therapeutics, Inc.较为活跃,换手率分别为3368.59%、714.84%、409.25%,振幅较大的相关个股有Dogwood Therapeutics, Inc.、Scisparc Ltd.、Biodexa Pharmaceuticals Plc,振幅分别为41.36%、40.24%、38.03%。Jasper Therapeutics, Inc.公司简介:Jasper Therapeutics Inc 是一家临床阶段的生物技术公司,致力于通过造血干细胞疗法实现治愈。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310221910abf30e40&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310221910abf30e40&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["JSPR","LENZ","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.jaspertherapeutics.com","stockEarnings":[{"period":"1week","weight":-0.0707},{"period":"1month","weight":-0.1231},{"period":"3month","weight":-0.3713},{"period":"6month","weight":-0.7155},{"period":"1year","weight":-0.9206},{"period":"ytd","weight":-0.92}],"compareEarnings":[{"period":"1week","weight":0.0034},{"period":"1month","weight":0.012},{"period":"3month","weight":0.0594},{"period":"6month","weight":0.1445},{"period":"1year","weight":0.1303},{"period":"ytd","weight":0.17}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Jasper Therapeutics, Inc.于2019年8月13日在特拉华州成立。该公司是一家临床阶段的生物技术公司,致力于通过针对肥大和造血干细胞的疗法实现治疗。该公司专注于开发和商业化更安全、更有效的治疗药物,用于治疗慢性自发性荨麻疹、低至中度风险骨髓增生异常综合征等疾病,以及干细胞移植和离体基因治疗的新型调理方案,这是一种在移植前在体外对细胞进行基因操作的技术。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.381182},{"month":2,"riseRate":0.5,"avgChangeRate":0.120825},{"month":3,"riseRate":0.166667,"avgChangeRate":-0.012922},{"month":4,"riseRate":0.5,"avgChangeRate":-0.048363},{"month":5,"riseRate":0.833333,"avgChangeRate":0.048413},{"month":6,"riseRate":0.5,"avgChangeRate":-0.094073},{"month":7,"riseRate":0.166667,"avgChangeRate":-0.099771},{"month":8,"riseRate":0.5,"avgChangeRate":-0.007485},{"month":9,"riseRate":0.166667,"avgChangeRate":-0.2127},{"month":10,"riseRate":0.166667,"avgChangeRate":-0.027786},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.069737},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.019043}],"exchange":"NASDAQ","name":"Jasper Therapeutics","nameEN":"Jasper Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.9","shortVersion":"4.35.9","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Jasper Therapeutics(JSPR)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Jasper Therapeutics(JSPR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Jasper Therapeutics,JSPR,Jasper Therapeutics股票,Jasper Therapeutics股票老虎,Jasper Therapeutics股票老虎国际,Jasper Therapeutics行情,Jasper Therapeutics股票行情,Jasper Therapeutics股价,Jasper Therapeutics股市,Jasper Therapeutics股票价格,Jasper Therapeutics股票交易,Jasper Therapeutics股票购买,Jasper Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Jasper Therapeutics(JSPR)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Jasper Therapeutics(JSPR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}